跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Eprosartan Tablets
Approved
化学药品
Eprosartan Tablets
Abbott Healthcare Products B.V.
🇨🇳 National Medical Products Administration
Approval Date
Jan 13, 2021
Approval ID
887otIAb0Vs
Company
Abbott Healthcare Products B.V.
Type
化学药品
Approval Details
Approval Id
887otIAb0Vs
Approval Number
国药准字HJ20171293
Generic Name
依普沙坦片
Generic Name En
Eprosartan Tablets
Trade Name
泰络欣
Drug Type
化学药品
Dosage Form
片剂
Strength
600mg
Reg Date
2021-01-13
Expired Date
2026-01-12
Company Name
Abbott Healthcare Products B.V.
Production Company Name
MYLAN LABORATORIES SAS
Company Detail Path
/organization/abbott-healthcare-products-b-v
Production Company Detail Path
/organization/mylan-laboratories-sas
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 13, 2021
Approval ID
887otIAb0Vs
Type
化学药品
Back to NMPA Approvals
泰络欣 - NMPA Drug Approval Details